• FirefoxInstall the new Firefox »
  •  Dow Down0.58% Nasdaq Down0.26%

    Tonix Pharmaceuticals Holding Corp (TNXP)

    -NasdaqGM
    6.39 Up 0.34(5.62%) 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development4,650  2,584  1,158  
    Selling General and Administrative6,238  4,078  2,220  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (10,888) (6,662) (3,379)
    Income from Continuing Operations
    Total Other Income/Expenses Net4  (2,788)(92)
    Earnings Before Interest And Taxes(10,884)(9,450)(3,470)
    Interest Expense -   -   -  
    Income Before Tax(10,884)(9,450)(3,470)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(10,884)(9,450)(3,470)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (10,884) (9,450) (3,470)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (10,884) (9,450) (3,470)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.